在肌肉中使用协同 mtZFN 架构进行临床翻译的线粒体基因疗法
Pavel A Nash1, Keira M Turner1, Christopher A Powell1
1MRC Mitochondrial Biology Unit, University of Cambridge, Cambridge, UK.
EMBO molecular medicine
|April 9, 2025
概括
这项研究表明,使用新型指核酶 (ZFNs) 的向线粒体基因疗法有效地减少了小鼠骨肌中的有害线粒体DNA (mtDNA) 突变,从而改善了疾病并证明了安全性.
科学领域:
- 生物化学 生物化学
- 遗传学 是一个遗传学.
- 分子生物学分子生物学
背景情况:
- 线粒体DNA (mtDNA) 突变会导致各种病理.
- 线粒体向指核酶 (mtZFNs) 可以减少突变的mtDNA并恢复细胞功能.
- 由于突变分布不均和突变多样化,组织特异性传递至关重要.
研究的目的:
- 评估一种新的mtZFN架构的有效性和安全性,用于骨肌肉中的体内线粒体基因治疗.
- 评估这种治疗对突变负载和表型救援在具有致病mtDNA突变的小鼠模型中的影响.
- 探索针对线粒体疾病的向基因疗法的潜力.
主要方法:
- 使用腺相关病毒 (AAV) 载体在体内将mtZFNs传递给小鼠模型中的骨肌肉.
- 评估了心脏和骨肌肉组织中mtDNA突变负载的减少.
- 通过免疫和炎症评估监测表型救援的分子标志物,并通过免疫和炎症评估评估安全.
主要成果:
- 证明有效降低心脏和骨肌肉中致病性mtDNA突变负载.
- 观察到与减少突变水平相关的分子表型救援.
- 证实了基因治疗的安全性,没有显著的不良免疫或炎症反应.
结论:
- 在活体线粒体基因治疗中,采用一种新的mtZFN架构,有效地减少mtDNA突变并拯救骨肌肉中的表型.
- 基于AAV的传递提供了针对性线粒体基因治疗的可行平台.
- 这种方法对开发线粒体疾病的治愈性,组织特异性治疗具有重大前景.
相关概念视频
00:59Gene Therapy
25.3K
Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
25.3K
02:59Animal Mitochondrial Genetics
7.5K
Among all the organelles in an animal cell, only mitochondria have their own independent genomes. Animal mitochondrial DNA is a double-stranded, closed-circular molecule with around 20,000 base pairs. Mitochondrial DNA is unique in that one of its two strands, the heavy, or H, -strand is guanine rich, whereas the complementary strand is cytosine rich and called the light, or L, -strand. Compared to nuclear DNA, mitochondrial DNA has a very low percentage of non-coding regions and is marked by...
7.5K
01:19Translocation of Proteins into the Mitochondria
3.1K
Mitochondrial precursors are translocated to the internal subcompartments via independent mechanisms involving distinct protein machineries called translocases.
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
Sorting of outer membrane proteins:
Mitochondrial outer membrane proteins are of two types: the transmembrane, beta-barrel porins, and the membrane-anchored, alpha-helical proteins. Beta-barrel porin precursors are translocated by the TOM complex and inserted into the outer mitochondrial membrane by the SAM complex. In contrast,...
3.1K
01:39Mitochondrial Protein Sorting
4.3K
Mitochondria are double-membrane organelles of the eukaryotes involved in cellular metabolism, signaling, ATP synthesis, and programmed cell death. Each of these processes requires specific proteins and enzymes that must be correctly sorted to the right mitochondrial subcompartment for the proper functioning of the organelle.
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
Most of these mitochondrial proteins are encoded by the nucleus and imported to the mitochondria as unfolded or loosely folded precursors. Mitochondrial precursors...
4.3K